Craft

Ginkgo Bioworks Holdings

Stock Price

$8

2024-10-29

Market Capitalization

$459.6 M

2024-10-29

Revenue

$227 M

FY, 2024

Ginkgo Bioworks Holdings Summary

Company Summary

Overview
Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions. It operates two segments: Cell Engineering and Biosecurity. The Cell Engineering segment is dedicated to research and development services relating to a cell programming platform. The Biosecurity segment is focused on biomonitoring and bioinformatic support services. The company caters to agriculture, biopharmaceutical, government, industrial, nutrition, and other sectors.
Type
Public
Status
Active
Founded
2020
HQ
Boston, MA, US | view all locations
Website
https://investors.ginkgobioworks.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

LocationsView all

1 location detected

  • Boston, MA HQ

    United States

    27 Drydock Avenue, 8th Floor

Ginkgo Bioworks Holdings Financials

Summary Financials

Revenue (FY, 2024)
$227.0M
Net income (FY, 2024)
($547.0M)
Cash (FY, 2024)
$561.6M
EBIT (FY, 2024)
($559.8M)
Enterprise value
($73.3M)

Footer menu